Explant, Differentiation and Culture
Confirmation of Assurance
Cordlife is the first and the only company in India to introduce the novel and patented technology of isolating, differentiating and expanding the two cell lines from the umbilical cord.
Cordlife with this technology assures its clients that their baby's stem cells have been processed with the most current state of the art techniques and these cells have the ability to be used for therapies in the future.
Explant Technology Confirms:
- The technology is capable of isolating two types of cell lines - MSC (Mesenchymal Stem Cells) & EpSC (Epithelial Stem Cells) from the Umbilical Cord.
- The proof that the two cell lines are alive and functioning in both tissue and expanded cells form
- Isolated cells are capable of further expansion under artificially controlled conditions outside the human body as per the requirement from DAY ONE maintaining their uniqueness.
- Developing the Liver Cells capable of producing Albumin and the Skin Cells producing Mucin from the differentiated cell lines gives the ultimate proof to the Functional Capacity of the cells.
Upon Explant Differentiation Culture, Bio Marker testing and Tissue verification the cord details will be stored with the Global Cord Registry, an international databank that enforces the Explant patents and authenticates the processing origin and quality of the stem cells, empowering the use of patented cell extraction and animal protein free culture and the capacity to use the cells for therapy.